EOFY, page-8

The SP will continue to fall until the company makes an announcement. The announcement they make could be one of any number of the ones listed below:

Ph1 DEP Cab recruitment/interim results updates
Ph2 DEP Doc recruitment/interim results updates
VIVAGEL licensing in other regions
Launch of ASPEN's Fleurstat
Mundifarma receiving approvals for VIVAGEL in any one of their regions
FDA Approval of VIVAGEL for the USA
Etc
Etc

The only reason the SP has eroded to the levels it is at today is due to over promising and not meeting timelines. There has not been any negative announcements since the 2012 Ph3 failure (that now has been shown to not be a failure at all!) and due to this fact, I remain very confident albeit frustrated in the company.

If you have the patience, the SP will rise again. It is just a matter of waiting for those announcements listed above to occur.